The roles of intracellular protein-degradation pathways in neurodegeneration

被引：0
作者：
David C. Rubinsztein
机构：
[1] Cambridge Institute for Medical Research,Department of Medical Genetics
[2] Addenbrooke's Hospital,undefined
来源：
Nature | 2006年 / 443卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Many late-onset neurodegenerative diseases, including Parkinson's disease and Huntington's disease, are associated with the formation of intracellular aggregates by toxic proteins. It is therefore crucial to understand the factors that regulate the steady-state levels of these 'toxins', at both the synthetic and degradation stages. The degradation pathways acting on such aggregate-prone cytosolic proteins include the ubiquitin–proteasome system and macroautophagy. Dysfunction of the ubiquitin–proteasome or macroautophagy pathways might contribute to the pathology of various neurodegenerative conditions. However, enhancing macroautophagy with drugs such as rapamycin could offer a tractable therapeutic strategy for a number of these diseases.
引用
收藏
页码：780 / 786
页数：6
相关论文
共 159 条
[1]  
Taylor JP(2002)Toxic proteins in neurodegenerative disease Science 296 1991-1995
[2]  
Hardy J(2005)What is the role of protein aggregation in neurodegeneration? Nature Rev. Mol. Cell Biol. 6 891-898
[3]  
Fischbeck KH(2001)Cause of neural death in neurodegenerative diseases attributable to expansion of glutamine repeats Nature 412 143-144
[4]  
Ross CA(2005)Disease modifying strategies for the treatment of Alzheimer's disease targeted at modulating levels of the β-amyloid peptide Biochem. Soc. Trans. 33 553-558
[5]  
Poirier MA(2002)Caspase cleavage of mutant huntingtin precedes neurodegeneration in Huntington's disease J. Neurosci. 22 7862-7872
[6]  
Perutz MF(2005)Cdk5 phosphorylation of huntingtin reduces its cleavage by caspases: implications for mutant huntingtin toxicity J. Cell Biol. 169 647-656
[7]  
Windle AH(1998)Caspase cleavage of gene products associated with triplet expansion disorders generates truncated fragments containing the polyglutamine tract J. Biol. Chem. 273 9158-9167
[8]  
Pangalos MN(2006)The ubiquitin proteolytic system: from a vague idea, through basic mechanisms, and onto human diseases and drug targeting Neurology 66 S7-S19
[9]  
Jacobsen SJ(2005)A series of ubiquitin binding factors connects CDC48/p97 to substrate multiubiquitylation and proteasomal targeting Cell 120 73-84
[10]  
Reinhart PH(2006)Inclusion body myopathy-associated mutations in p97/VCP impair endoplasmic reticulum-associated degradation Hum. Mol. Genet. 15 189-199
12345678910